All Substitutes
Loading...
Disclaimer
Did you find this information helpful?
  Â
Palbinas 125mg Capsule
Prescription Required
Salt Composition : Palbociclib
Manufacturer : GLENMARK PHARMACEUTICALS LTD
Origin of Medicine : India
21 Capsule(s) In A Box
PAP Information : Â Â Contact us for latest updates
Program Overview: GLENMARK PHARMACEUTICALS LTD, Patient Assistance Program (PAP) is dedicated to helping patients in need of palbinas 125mg capsule. The program aims to provide eligible patients with access to the medication at a more affordable cost.
Program Benefits: Patient assistance programs (PAPs) are sponsored by pharmaceutical companies, and are an important step towards lowering overall therapy costs for patients. The purpose of these initiatives is to provide financial assistance to patients so they can obtain drugs at low or no cost. MrMed will guide you through the procedure and ensure you receive your PAP medication correctly.Â
Contact us for the latest updates on this exclusive offer.
Eligibility Criteria: To qualify for the palbinas Patient Assistance Program (PAP), you must meet specific criteria, including having a valid prescription for Palbociclib 125mg from a medical oncologist and being an Indian patient with a valid identity card. Eligibility is determined based on the diagnosed condition and program-specific requirements.
Contact Information: If you have any questions or need assistance with the application process, our dedicated patient support team is here to help. You can reach us by phone at 89391 69999 or email us at [email protected].
Please note that MrMed is not involved in the PAP program. They offer free consultations to patients to provide information about the program. Patients eligible for the PAP program by glenmark can avail of it without having to purchase the medication from MrMed.
Patient Assistance Programs
Program Overview: GLENMARK PHARMACEUTICALS LTD, Patient Assistance Program (PAP) is dedicated to helping patients in need of palbinas 125mg capsule. The program aims to provide eligible patients with access to the medication at a more affordable cost.
Program Benefits: Patient assistance programs (PAPs) are sponsored by pharmaceutical companies, and are an important step towards lowering overall therapy costs for patients. The purpose of these initiatives is to provide financial assistance to patients so they can obtain drugs at low or no cost. MrMed will guide you through the procedure and ensure you receive your PAP medication correctly.Â
Contact us for the latest updates on this exclusive offer.
Eligibility Criteria: To qualify for the palbinas Patient Assistance Program (PAP), you must meet specific criteria, including having a valid prescription for Palbociclib 125mg from a medical oncologist and being an Indian patient with a valid identity card. Eligibility is determined based on the diagnosed condition and program-specific requirements.
Contact Information: If you have any questions or need assistance with the application process, our dedicated patient support team is here to help. You can reach us by phone at 89391 69999 or email us at [email protected].
Please note that MrMed is not involved in the PAP program. They offer free consultations to patients to provide information about the program. Patients eligible for the PAP program by glenmark can avail of it without having to purchase the medication from MrMed.
Introduction to Palbinas 125mg Capsule
Palbinas 125 mg is a targeted therapy containing the active constituent palbociclib. It belongs to the group of anticancer medications known as cyclin-dependent kinase inhibitors. It is used in treating hormone receptor-positive, human epidermal growth factor 2 negative advanced or metastatic (has spread to other parts of the body) breast cancer. Cancer is a condition in which cells multiply in an uncontrolled and abnormal manner. It is given in combination with certain other anticancer medications. Â
The common side effects that are likely to associate with Palbinas 125 mg capsule are nausea, vomiting, diarrhea, tiredness, hair loss, dry skin, rash, infections, nose bleed, decreased appetite, low blood cell counts, swelling of lips and mouth, changes in taste, dry eye, blurred vision, and increased tearing. Inform your doctor if any of these side effects disturb or persist in you. Â
Inform your healthcare provider if you are allergic to Palbinas 125 mg capsule and its ingredients. Before taking this medicine, it is vital to inform your doctor if you have any signs of infections (fever, chills, or sore throat), liver disorders, kidney disorders, or intolerance to some sugars. Consult your physician immediately if you experience symptoms such as dry cough, chest pain, or difficulty breathing, as it could indicate lung inflammation. Make sure you inform your physician of all the medicines, including supplements and herbal medicines; you are taking before you start treatment with this medication. Use effective birth control during the treatment and at least three weeks after the last dose. It is not recommended for adolescents and children under 18 years of age.Â
Uses of Palbinas 125mg Capsule
- Treatment of hormone receptor (HR)-positive, human epidermal growth factor 2 (HER2)-negative advanced or metastatic breast cancer.
Therapeutic Effects of Palbinas 125mg Capsule
Palbinas 125 mg capsule works by blocking the protein called cyclin-dependent kinases 4 and 6, which are vital for the division and growth of cells. By blocking these proteins, this medication slows the growth and prevents the cancer cells from spreading.Â
Interaction of Palbinas 125mg Capsule with other drugs
Inform your doctor about all medications, including prescribed, over-the-counter, nutritional, or vitamin supplements and herbal products that you are taking or have taken before the treatment. Concurrent use of Palbinas 125 mg capsule with CYP3A4 inhibitors such as fentanyl has reported increased fentanyl toxicity. Certain medications may interact with the effectiveness of this drug.
More Information about Palbinas 125mg Capsule
- Keep Palbinas 125 mg capsule out of sight and reach of children.
- Store at 20°C to 25°C.
How to consume Palbinas 125mg Capsule
Take Palbinas 125 mg capsule exactly as prescribed by your doctor. Take this medication once a day at the same time with food. Swallow this capsule as a whole with a glass of water. Avoid crushing, breaking, or chewing the capsule.Â
Safety Advices for Palbinas 125mg Capsule
 Â
Pregnancy
 Â
It is not recommended to take Palbinas 125 mg capsule during pregnancy as it can harm the unborn baby. Women with childbearing potential should use effective contraceptives during treatment and for at least three weeks after treatment.Â
 Â
Breast Feeding
 ÂIt is not recommended to take Palbinas 125 mg capsule while breastfeeding as it is not known whether it passes into the breast milk. Â
 Â
Lungs
 Â
It is not unknown whether Palbinas 125 mg can be administered to patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.
 Â
Liver
  Inform your physician if you have any liver disorders before taking Palbinas 125 mg capsule, as it should be used with caution in liver disorder patients.
 Â
Alcohol
 ÂIt is unknown whether it is safe to drink alcohol while taking Palbinas 125 mg capsule. Check with your doctor for advice.Â
 Â
Driving
  Palbinas 125 mg capsule can cause tiredness. Avoid driving if you are unwell.
Side Effects of Palbinas 125mg Capsule
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.Â
Serious:
- Blood disorder (fever, chills, shortness of breath, weakness, bleeding, or bruising)
- Lung inflammation (chest pain, dry cough, or difficulty breathing)
Common:
- Tiredness
- Hair loss
- Dry skin, rash
- Infections
- Low blood cell counts
- Decreased of appetite
- Nausea, vomiting
- Diarrhea
- Swelling of lips and mouth
- Changes in taste
- Nose bleed
- Dry eye, blurred vision, increased tearing
Word of Advice
During Palbinas 125 mg capsule treatment, it is advised to avoid grapefruit and its juices and preparations containing St. John's wort. It is recommended to use effective birth control while receiving treatment as well as for at least three weeks after the final dose for females and at least fourteen weeks after the final dose for males. This medication may reduce fertility, so discuss with the physician if you have any concerns. Your doctor may recommend regular blood tests to determine whether Palbinas 125 mg capsule affects your blood cells.
FAQs
Q 1. Is Palbinas 125 mg capsule targeted therapy?
Yes, Palbinas 125 mg capsule is a targeted therapy. This medication belongs to the class of cyclin-dependent kinase inhibitors.
Q 2. Do you lose hair on Palbinas 125 mg capsule?
Yes, Taking Palbinas 125 mg capsule can cause hair loss or hair thinning. It is one of the side effects of this medication. Consult your doctor if anyside effects disturb you.
Q 3. Can children use Palbinas 125 mg capsule?
No, Palbinas 125 mg capsule is not recommended for adolescents and children under 18.
Q 4. Does Palbinas 125 mg capsule affect fertility?
Yes, Palbinas 125 mg capsule may reduce fertility in men. It may affect your ability to become a father and a child. Hence, men should consider sperm preservation before taking this medication.
Q 5. Does Palbinas 125 mg capsule affect blood cell count?
Palbinas 125 mg capsule might reduce the number of white blood cells and weaken the immune system. It could lead to an increase in the risk of infections. Regular blood tests while taking Palbinas 125 mg capsule are advised.
Fact Box of Palbinas 125mg Capsule
Molecule name: Palbociclib | Therapeutic class: Cyclin-dependent kinase inhibitor |
Pharmacological class: Anti-Neoplastics | Indications: HR-positive, HER2-negative advanced or metastatic breast cancer |
References
- Pfizer Limited, Electronic medicines compendium (emc), [Revised on June 2021] [ Accessed on 26 Nov 2022], https://www.medicines.org.uk/emc/files/pil.4449.pdf
- Pfizer Labs, US Food and Drug Administration, [Revised on March 2017] [ Accessed on 26 Nov 2022], https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207103s004lbl.pdf
- Neha S Mangini et al; Palbociclib: A Novel Cyclin-Dependent Kinase Inhibitor for Hormone Receptor-Positive Advanced Breast Cancer; The Annals of Pharmacotherapy; Published on Nov 2015; Accessed on 26/11/2022; https://pubmed.ncbi.nlm.nih.gov/26324355/
- Palbace; Pfizer; Revised on Oct 2021; Accessed on 26/11/2022; https://labeling.pfizer.com/ShowLabeling.aspx?id=14029
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
